Complementary and Integrative Therapies for Women’s Health

Dear Colleagues,

Due to social and economic changes, including population aging, birthrate declines, and increases in economic activity, the factors and countermeasures related to women’s health are changing rapidly. 
Women’s health is related to the health of future generations, not on the individual level, but on the social and economic levels, and realization of this has contributed to the concept of comprehensive women’s health management, which includes the social and environmental factors that affect females’ health.
Approaching women’s health issues efficiently necessitates changes in awareness, social culture, and medical information and systems as well as the professional approach to delivering health care throughout women’s lives.
One needed change is to treat not only pregnancy and childbirth, but also diseases specific to women and serious health problems that occur more frequently in women using an approach that considers the life cycle. Countermeasures should also integrate various medical technologies.
Endocrinologic diseases, including infertility, miscarriage, premenopausal syndrome, and polycystic ovary syndrome, are complicated processes controlled by endocrine regulation. Complementary and integrative therapies (CIT) has been used widely to treat women’s reproductive endocrinologic diseases, but CIT’s safety and effectiveness have not been fully evaluated. To close these gaps, the use of CIT to treat women’s reproductive endocrinologic diseases must be evaluated using scientific research methods.
In this special issue, we provide scientific evidence regarding the use of CIT to manage women’s health.
The potential topics include but are not limited to the following:
• The clinical efficacy of CIT for treating dysmenorrhea, women’s infertility, perimenopausal syndrome, polycystic ovary syndrome, etc.
• The mechanisms of CIT, including acupuncture, aromatherapy, herbal medicine, hypnosis, massage, meditation, and tai chi.
• The adverse effects and risks of using CIT to treat women’s reproductive endocrine disorders.

Prof. Myeong Soo Lee, Associate Prof. Fan Qu and Dr. Hye Won Lee

Guest Editors

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1500 USD. Submitted manuscripts should be well formatted in good English.